Remnant cholesterol contributes to residual lipid risk after acute coronary syndromes

被引：0
|
作者：
Wenzl, F. [1 ]
Kraler, S. [1 ]
Raeber, L. [2 ]
Von Eckardstein, A. [3 ]
Matter, C. [4 ]
Gencer, B. [5 ]
Nanchen, D. [6 ]
Rodondi, N. [7 ]
Mach, F. [5 ]
Luescher, T. [8 ]
机构：
[1] Univ Zurich, Ctr Mol Cardiol, Zurich, Switzerland
[2] Inselspital Bern, Bern Univ Hosp, Dept Cardiol, Bern, Switzerland
[3] Univ Hosp Zurich, Inst Clin Chem, Zurich, Switzerland
[4] Univ Hosp Zurich, Dept Cardiol, Zurich, Switzerland
[5] Univ Hosp Geneva, Dept Cardiol, Geneva, Switzerland
[6] Univ Lausanne, Ctr Primary Care & Publ Hlth, Lausanne, Switzerland
[7] Inselspital Bern, Bern Univ Hosp, Dept Gen Internal Med, Bern, Switzerland
[8] Imperial Coll London, Royal Brampton Hosp, London, England
来源：
EUROPEAN HEART JOURNAL | 2022年 / 43卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1169 / 1169
页数：1
相关论文
共 50 条
  • [31] Lipid Lowering Drugs in Acute Coronary Syndromes (ACS)
    Natalie Arnold
    Wolfgang Koenig
    [J]. Current Atherosclerosis Reports, 2023, 25 : 939 - 946
  • [32] Optimizing lipid management in patents with acute coronary syndromes
    Pepine, CJ
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 91 (4A): : 30B - 35B
  • [33] PROGNOSTIC IMPACT OF RESIDUAL INFLAMMATORY RISK AFTER ACUTE CORONARY SYNDROME
    Toso, A.
    Leoncini, M.
    Villani, S.
    Tropeano, F.
    Maioli, M.
    Bellandi, F.
    [J]. EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24 (SUPPL C)
  • [34] Elevated remnant cholesterol is a risk factor for acute ischemic stroke
    Feng, Qian
    Li, Hao
    Zhang, Ru-Yang
    Sun, Li
    Zhang, Shi-Yu
    Chen, Yue
    Zhang, Yue
    Shan, Bao-Shuai
    Zhao, Zhong
    Zhou, Hua
    Xu, Xingshun
    [J]. JOURNAL OF STROKE & CEREBROVASCULAR DISEASES, 2024, 33 (08):
  • [35] Expected impact of applying new 2013 AHA/ACC cholesterol guidelines criteria on the recommended lipid target achievement after acute coronary syndromes
    Gencer, Baris
    Auer, Reto
    Nanchen, David
    Raeber, Lorenz
    Klingenberg, Roland
    Carballo, David
    Blum, Manuel
    Vogt, Pierre
    Carballo, Sebastian
    Meyer, Philippe
    Matter, Christian M.
    Windecker, Stephan
    Luescher, Thomas F.
    Mach, Francois
    Rodondi, Nicolas
    [J]. ATHEROSCLEROSIS, 2015, 239 (01) : 118 - 124
  • [36] Effect of admission cholesterol levels on acute coronary syndromes' outcome
    Mateus, P. S.
    Ferreira, C.
    Ferreira, A.
    Moreira, J. I.
    [J]. EUROPEAN HEART JOURNAL, 2013, 34 : 573 - 573
  • [37] Lipid-lowering Therapy and LDL Cholesterol in Patients after acute Coronary Syndrome
    Haider, P.
    Galli, L.
    Schrutka, L.
    Distelmaier, K.
    Wojta, J.
    Hengstenberg, C.
    Krychtiuk, K.
    Speidl, W.
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 : S419 - S419
  • [38] Impact of availability and use of coronary interventions on the prescription of aspirin and lipid lowering treatment after acute coronary syndromes
    Steg, PG
    Lung, B
    Feldman, LJ
    Cokkinos, D
    Deckers, J
    Fox, KAA
    Keil, U
    Maggioni, AP
    [J]. HEART, 2002, 88 (01) : 20 - 24
  • [39] Bleeding risk and Acute Coronary Syndromes in the Elderly
    Bounhoure, Jean-Paul
    Montastruc, Jean-Louis
    [J]. BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2011, 195 (08): : 1981 - 1987
  • [40] Remnant Lipoproteinemia is a Risk of Non-Culprit Attenuated Coronary Plaques Detected by Grayscale Intravascular Ultrasound in Patients with Acute Coronary Syndromes
    Obata, Jyun-Ei
    Kitta, Yoshinobu
    Saito, Yukio
    Nakamura, Takamitsu
    Sano, Keita
    Fujioka, Daisuke
    Deyama, Juntaro
    Uematsu, Manabu
    Kawabata, Ken-ichi
    Kugiyama, Kiyotaka
    [J]. CIRCULATION, 2011, 124 (21)
12345